Literature DB >> 31076291

Pneumocystosis pneumonia: A comparison study between HIV and non-HIV immunocompromised patients.

I Rego de Figueiredo1, R Vieira Alves2, D Drummond Borges2, M Torres3, F Lourenço2, A M Antunes2, H Gruner2, A Panarra2.   

Abstract

Pneumocystis pneumonia (PCP) is caused by the fungus Pneumocystis jirovecii, and its incidence has been on the rise in immunosuppressed patients without HIV. We performed a cross sectional study in patients with PCP and assessed demographic, clinical presentation and outcome measures such as mechanical ventilation and mortality differences between HIV and non-HIV patients. The two groups were statistically significantly different, with the HIV group being younger (45.5 years vs 55.9 years, p-value 0.001) and mostly composed of male patients (69% vs 31%, p-value <0.001). Also, the HIV patients had higher percentage of respiratory complaints (90% vs 68%, p-value 0.02) and lactate dehydrogenase elevation (73% vs 40%, p-value 0.001). In contrast, non-HIV patients had worse outcomes with higher incidence of invasive mechanical ventilation (23% vs 46%, p-value 0.005) and in-hospital mortality (13% vs 37%, p-value 0.002). These results reflect the literature and should raise awareness to a potentially fatal medical situation of increasing incidence.
Copyright © 2019 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  HIV; Non-HIV immunocompromised; Pneumocystosis; Pneumonia

Mesh:

Substances:

Year:  2019        PMID: 31076291     DOI: 10.1016/j.pulmoe.2019.04.003

Source DB:  PubMed          Journal:  Pulmonology        ISSN: 2531-0429


  11 in total

1.  Pneumocystis carinii Major Surface Glycoprotein Dampens Macrophage Inflammatory Responses to Fungal β-Glucan.

Authors:  Theodore J Kottom; Deanne M Hebrink; Eva M Carmona; Andrew H Limper
Journal:  J Infect Dis       Date:  2020-09-01       Impact factor: 5.226

2.  Evolving epidemiology of pneumocystis pneumonia: Findings from a longitudinal population-based study and a retrospective multi-center study in Germany.

Authors:  Benedikt Kolbrink; Jubin Scheikholeslami-Sabzewari; Christoph Borzikowsky; Friedrich A von Samson-Himmelstjerna; Andrew J Ullmann; Ulrich Kunzendorf; Kevin Schulte
Journal:  Lancet Reg Health Eur       Date:  2022-05-15

3.  Preliminary Study on the Combination Effect of Clindamycin and Low Dose Trimethoprim-Sulfamethoxazole on Severe Pneumocystis Pneumonia After Renal Transplantation.

Authors:  Zhun-Yong Gu; Wen-Jun Liu; Dan-Lei Huang; Yu-Jing Liu; Hong-Yu He; Cheng Yang; Yi-Mei Liu; Ming Xu; Rui-Ming Rong; Du-Ming Zhu; Zhe Luo; Min-Jie Ju
Journal:  Front Med (Lausanne)       Date:  2022-05-06

4.  Pneumocystis jirovecii Disease: Basis for the Revised EORTC/MSGERC Invasive Fungal Disease Definitions in Individuals Without Human Immunodeficiency Virus.

Authors:  Katrien Lagrou; Sharon Chen; Henry Masur; Claudio Viscoli; Catherine F Decker; Livio Pagano; Andreas H Groll
Journal:  Clin Infect Dis       Date:  2021-03-12       Impact factor: 9.079

5.  EphA2 Is a Lung Epithelial Cell Receptor for Pneumocystis β-Glucans.

Authors:  Theodore J Kottom; Kyle Schaefbauer; Eva M Carmona; Andrew H Limper
Journal:  J Infect Dis       Date:  2022-02-01       Impact factor: 7.759

6.  [Adequacy to diagnostic recommendations in patients with Pneumocystis jirovecii pneumonia treated with intravenous pentamidine].

Authors:  L Cantarelli; F Gutiérrez Nicolás; G J Nazco Casariego; S García Gil
Journal:  Rev Esp Quimioter       Date:  2021-12-01       Impact factor: 1.553

7.  Nomograms for Death from Pneumocystis jirovecii Pneumonia in HIV-Uninfected and HIV-Infected Patients.

Authors:  Qiuyue Feng; Jingjing Hao; Ang Li; Zhaohui Tong
Journal:  Int J Gen Med       Date:  2022-03-15

8.  Simian Immunodeficiency Virus Infection Mediated Changes in Jejunum and Peripheral SARS-CoV-2 Receptor ACE2 and Associated Proteins or Genes in Rhesus Macaques.

Authors:  Nongthombam Boby; Xuewei Cao; Kelsey Williams; Shiva Kumar Goud Gadila; Monica N Shroyer; Peter J Didier; Sudesh K Srivastav; Arpita Das; Kate Baker; Qiuying Sha; Bapi Pahar
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 8.786

9.  Survey of the Transcription Factor Responses of Mouse Lung Alveolar Macrophages to Pneumocystis murina.

Authors:  Theodore J Kottom; Kyle Schaefbauer; Eva M Carmona; Andrew H Limper
Journal:  Pathogens       Date:  2021-05-08

10.  Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway.

Authors:  Stine Grønseth; Tormod Rogne; Raisa Hannula; Bjørn Olav Åsvold; Jan Egil Afset; Jan Kristian Damås
Journal:  BMC Infect Dis       Date:  2021-07-07       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.